Literature DB >> 19491984

Incidence of postoperative endophthalmitis in a high-volume cataract surgicentre in Canada.

John C Lloyd1, Rosa Braga-Mele.   

Abstract

OBJECTIVE: To determine the incidence of endophthalmitis at a high-volume, multisurgeon Canadian surgicentre and compare the endophthalmitis incidence, incision techniques, and prophylactic regimens with other published data in the worldwide literature.
DESIGN: Retrospective, consecutive case series. PARTICIPANTS: Patients (13 931 eyes) who underwent cataract surgery at the Kensington Eye Institute, Toronto, Ont., from January 9, 2006, to January 6, 2008.
METHODS: Cases of endophthalmitis were identified from surgeon quality assurance reports. Prophylactic regimens, incision techniques, organisms cultured, and visual outcomes were reviewed in each case. All surgeons were surveyed regarding their incision techniques and prophylactic regimens.
RESULTS: Endophthalmitis developed in 6 eyes (incidence 0.043%). No causative organism predominated, and only 1 patient had severe vision loss to less than counting fingers. More cases of endophthalmitis (4 of 6) occurred in patients not receiving fourth-generation fluoroquinolones, despite approximately 75% of surgeons using these drugs before and after surgery (odds ratio 6.3, relative risk 6.3). No intracameral antibiotics were used in any cases, and all incisions were clear corneal.
CONCLUSIONS: Our incidence of postoperative endopthalmitis after cataract surgery was 0.043%. Slight evidence of reduced endophthalmitis with the use of fourth-generation fluoroquinolones was noted. Our endophthalmitis incidence compares favourably with other published rates in the medical literature, and this rate was achieved without intracameral antibiotic use in a centre that uses exclusively topical anesthesia and clear corneal incisions.

Entities:  

Mesh:

Year:  2009        PMID: 19491984     DOI: 10.3129/i09-052

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  8 in total

1.  Toll-like receptor 2 ligand-induced protection against bacterial endophthalmitis.

Authors:  Ashok Kumar; Christopher N Singh; Inna V Glybina; Tamer H Mahmoud; Fu-Shin X Yu
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

Review 2.  Molecular Diagnostics for Ocular Infectious Diseases: LXXVIII Edward Jackson Memorial Lecture.

Authors:  Russell N Van Gelder
Journal:  Am J Ophthalmol       Date:  2021-12-16       Impact factor: 5.258

3.  Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis.

Authors:  Pawan Kumar Singh; David M Donovan; Ashok Kumar
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

4.  Perioperative prophylaxis for endophthalmitis after cataract surgery in iran.

Authors:  Marzieh Katibeh; Hossein Ziaei; Mahboobe Mirzaei; Armen Eskandari; Hamidreza Moein; Masumeh Kalantarion; Mohammadali Javadi
Journal:  J Ophthalmic Vis Res       Date:  2015 Jan-Mar

5.  Incidence and Determinants of Endophthalmitis within 6 Months of Surgeries over a 2-Year Period at King Khaled Eye Specialist Hospital, Saudi Arabia: A Review.

Authors:  Rajiv Khandekar; Saeed Al-Motowa; Hind M Alkatan; Mohammed Karaoui; Anne Ortiz
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

Review 6.  Cataract surgery and methods of wound closure: a review.

Authors:  Cynthia Matossian; Sarah Makari; Richard Potvin
Journal:  Clin Ophthalmol       Date:  2015-05-22

Review 7.  Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis.

Authors:  He Cao; Lu Zhang; Liping Li; Singkai Lo
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

Review 8.  The ocular surface bacterial contamination and its management in the prophylaxis of post cataract surgery endophthalmitis.

Authors:  Daniela Soare Simina; Ilie Larisa; Costeliu Otilia; Ghiță Ana Cristina; Mary Voinea Liliana; Mihai Ghiță Aurelian
Journal:  Rom J Ophthalmol       Date:  2021 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.